You have 9 free searches left this month | for more free features.

Pacritinib

Showing 1 - 25 of 33

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

KSHV Inflammatory Cytokine Syndrome (KICS), Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease Trial run by

Not yet recruiting
  • KSHV Inflammatory Cytokine Syndrome (KICS)
  • Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease
  • Pacritinib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 2, 2023

Drug Interactions Trial in Austin (CYP450 Cocktail and Transporter Substrates with Pacritinib, Part 2 -Group A Bosentan 125 mg

Recruiting
  • Drug Interactions
  • CYP450 Cocktail and Transporter Substrates with Pacritinib
  • +2 more
  • Austin, Texas
    PPD - Austin Research Unit
Jan 13, 2023

Hepatic Impairment Trial (oral dose of 200 mg pacritinib twice daily (BID))

Not yet recruiting
  • Hepatic Impairment
  • oral dose of 200 mg pacritinib twice daily (BID)
  • (no location specified)
Sep 23, 2022

T-Cell Tumor, Lymphoproliferative Disorders Trial in Ann Arbor (Pacritinib)

Not yet recruiting
  • T-Cell Neoplasm
  • Lymphoproliferative Disorders
  • Pacritinib
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Oct 6, 2022

Prostate Cancer Trial in Milwaukee (Pacritinib)

Recruiting
  • Prostate Cancer
  • Pacritinib
  • Milwaukee, Wisconsin
    Froedtert & the Medical College of Wisconsin
Jul 18, 2022

Graft Vs Host Disease, GVHD Trial in Tampa, Minneapolis (Pacritinib, Sirolimus, Tacrolimus)

Active, not recruiting
  • Graft Vs Host Disease
  • GVHD
  • Pacritinib
  • +2 more
  • Tampa, Florida
  • +1 more
Jul 27, 2022

Myelofibrosis Trial in Belgium, Netherlands (Pacritinib)

Active, not recruiting
  • Myelofibrosis
  • Pacritinib
  • Antwerpen, Belgium
  • +11 more
Aug 19, 2022

Primary Myelofibrosis Trial (Pacritinib)

Withdrawn
  • Primary Myelofibrosis
  • Pacritinib
  • (no location specified)
May 3, 2021

Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Chronic Lymphocytic Leukemia Trial in Ann Arbor (Pacritinib)

Terminated
  • Lymphoma, T-Cell, Cutaneous
  • +6 more
  • Pacritinib
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Jan 20, 2021

COVID19, COVID-19, COVID Trial in United States (Pacritinib, Placebo)

Terminated
  • COVID19
  • +2 more
  • Pacritinib
  • Placebo
  • Orange, California
  • +20 more
Sep 23, 2021

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post- Essential Thrombocythemia Myelofibrosis Trial in Worldwide

Completed
  • Primary Myelofibrosis
  • +2 more
  • Pacritinib
  • Phoenix, Arizona
  • +61 more
May 5, 2022

Breast Cancer Trial in Singapore (Pacritinib)

Recruiting
  • Breast Cancer
  • Pacritinib
  • Singapore, Singapore
    National University Hospital
Aug 17, 2020

Myelofibrosis Trial in Munich, Chisinau (Pacritinib)

Completed
  • Myelofibrosis
  • Pacritinib
  • Munich, Germany
  • +1 more
Mar 4, 2020

Drug Interaction Study Trial in Daytona Beach (Pacritinib, Clarithromycin, Pacritinib and Clarithromycin)

Completed
  • Drug Interaction Study
  • Pacritinib
  • +2 more
  • Daytona Beach, Florida
    Covance Clinical Research Unit
Jan 27, 2020

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Pacritinib
  • Physician's Choice medications
  • Birmingham, Alabama
  • +151 more
Aug 22, 2022

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Terminated
  • Primary Myelofibrosis
  • +2 more
  • Pacritinib
  • Best Available Therapy
  • Scottsdale, Arizona
  • +121 more
Oct 21, 2021

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Terminated
  • Primary Myelofibrosis
  • +2 more
  • Pacritinib
  • Best Available Therapy
  • Scottsdale, Arizona
  • +80 more
Sep 25, 2020

Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Therapy-Related Acute Myeloid Leukemia Trial in

Completed
  • Recurrent Adult Acute Myeloid Leukemia
  • +3 more
  • Pacritinib
  • +5 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Jan 23, 2019

Myeloproliferative Diseases Trial in Houston (drug, behavioral, procedure)

Terminated
  • Myeloproliferative Diseases
  • Pacritinib
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 4, 2018

Leukemia Trial in Houston (Pacritinib, 5-azacitidine, Decitabine)

Terminated
  • Leukemia
  • Pacritinib
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 18, 2018

Myelofibrosis Trial in Munich, Chisinau, Bucharest (Pacritinib)

Completed
  • Myelofibrosis
  • Pacritinib
  • Munich, Germany
  • +2 more
Oct 18, 2018

Acute Myeloid Leukemia (AML) Trial in New York (Pacritinib, Decitabine, Cytarabine)

Terminated
  • Acute Myeloid Leukemia (AML)
  • Pacritinib
  • +2 more
  • New York, New York
    Weill Cornell Medical College
Jun 13, 2018

Ulcerative Colitis, Thromboembolism Trial in Madrid (Tofacitinib, Infliximab Adalimumab y Golimumab)

Recruiting
  • Ulcerative Colitis
  • Thromboembolism
  • Madrid, Spain
    Hospital Universitario de La Princesa
Aug 2, 2022

NSCLC, Nonsmall Cell Lung Cancer, NSCLC Trial in Saint Louis (Pacritinib, Erlotinib)

Terminated
  • Non-Small Cell Lung Cancer
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 23, 2018

Myeloproliferative Tumor Trial in New York (Vactosertib)

Recruiting
  • Myeloproliferative Neoplasm
  • New York, New York
    Weill Medical College of Cornell University
Dec 20, 2021